Congratulations! Kexing Biopharm (688136.SH) was awarded by the" Annual Top 20 Chinese Biopharmaceutical Entreprises"
On 12 July 2Kexing Biopharm22, Menet held the award ceremony of the "Annual Top 1Kexing BiopharmKexing Biopharm China's Pharmaceutical Entreprises in 2Kexing Biopharm21", in which 5 sub-lists of the pharmaceutical industries had been announced. This event showcased the professionalism and influence of the top companies in China's pharmaceutical industry. With the solid R&D and production strength and the strong marketing and promotion access of Kexing Biopharm, it has been selected for the list of "Top 2Kexing Biopharm Chinese Biopharmaceutical Companies in 2Kexing Biopharm21 (Blood Products, Vaccines, Insulin Approaches)".
The nominated list of the Annual Top 100 China's Pharmaceutical Entreprises in 2021 was defined through intense selection. Menet has organized an expert committee for this event, through the exclusive database with the 3 Terminals (public hospitals, retail pharmacies, primary care) and 6 Markets (including markets of hospitals, pharmacies and healthcare centres in different levels and sizes) in the Chinese (bio)pharmaceutical industry, the final list was made according to an enterprise's innovative driving force in the biopharmaceutical industry and professional promotion force in the public market.
About Kexing Biopharm
Kexing Biopharm Co.,Ltd. (short in Kexing Biopharm, stock symbol 688136. SH) is an international innovative biopharmaceutical enterprise mainly engaged in the R&D, production and sales of recombinant protein therapeutics and microecological agents. The entreprise focuses on the therapeutic fields of antiviral, oncology, immunology, haematology, digestion and degenerative diseases, as well as other technical directions such as new proteins, new antibodies, and nucleic acid drugs. Committed to serving global patients with biotechnology, Kexing Biopharm became a leader of high-quality biopharmaceutical producers through adopting the "innovation + overseas commercialization" platform development model.
Kexing Biopharm's main products include the recombinant protein therapeutics " Human Erythropoietin (EPOSINO)", " Human Interferon ?1b (SINOGEN)" and " Human Granulocyte Colony-stimulating Factor (WHITE-C)", as well as the microecological agent "Combined Clostridium Butyricum and Bifidobacterium (CLOBICO)".The company's core products are firmly at the forefront of similar varieties in China, covering over 19,000 terminals in various provinces and cities across the country, nearly 7,000 ranked hospitals. In addition, Kexing Biopharm has gained market access permission and achieved sales in nearly 40 countries around the world, including Brazil, the Philippines, and Indonesia.
https://www.menet.com.cn/info/202207/202207122212121212_144039.shtml
http://www.kexing.com/eindex.html
ข่าวKexing Biopharm+o:editorวันนี้
FILA ต้อนรับซัมเมอร์ด้วยแคมเปญ FILA ELEVATION 'Elevate Your Every Day'
FILA ต้อนรับซัมเมอร์ด้วยแคมเปญ FILA ELEVATION 'Elevate Your Every Day' #WITHFILATH ชวน หยิ่น-วอร์ และแก๊งเพื่อน อัปลุคเท่ด้วยรองเท้า FILA Echappe MS V2 FILA แบรนด์สปอร์ตแวร์แฟชั่นที่ผสมผสานความคลาสสิกและความทันสมัยเข้าด้วยกัน ชวนทุกคนมาอัปลุคให้โดดเด่นในทุกวัน กับแคมเปญ FILA ELEVATION 'Elevate Your Every Day' #WITHFILATH ด้วยแฟชั่นเซ็ตของ 5 หนุ่มสุดฮอต อย่าง หยิ่น-อานันท์ และ วอร์-วนรัตน์ ตั๋ง-ชินดิศ พร้อม-ราชภัทร และ เน-เนติพัฒน์ ที่มิกซ์แอนด์แมตช์ลุคสุดเท่กับรองเท้า FILA Echappe MS V2 คอล
ซัมเมอร์นี้…น่ารักเกินต้าน! "เก่ง - น้ำปิง" ควงคู่สาดความสดใส ในกิจกรรม Haier Dream For Fan Season 5: Haier Bloom into Summer
—
อยู่ ๆ หน้าร้อนก็กลายเป็นน...